for the Clinical Pharmacy Cardiac Risk Service Study Group
Articles
August 7th 2009
Outcomes of Patients Discharged From Pharmacy-Managed Cardiovascular Disease Management
Kari L. Olson, PharmD Thomas Delate, PhD Jon Rasmussen, PharmD Tammy L. Humphries, PharmD John A. Merenich, MD for the Clinical Pharmacy Cardiac Risk Service Study Group
Lipid levels can remain controlled with electronic laboratory reminder letters for most patients with coronary artery disease discharged from a cardiovascular disease management program.
October 1st 2007
Angiotensin-converting Enzyme Inhibitor Therapy for Coronary Artery Disease and Diabetes Mellitus
Karen J. McConnell, PharmD Emily B. Zadvorny, PharmD Anne M. Denham, PharmD Sheila L. Kasten, PharmD Kara A. Hutka, PharmD Cedar R. Koetting, PharmD John A. Merenich, MD for the Clinical Pharmacy Cardiac Risk Service Study Group
Latest Updated Articles
Published: November 15th 2024 | Updated: November 19th 2024
FDA Approves Revumenib for R/R Acute Leukemia With a KMT2A Translocation
Published: April 1st 2024 | Updated: November 5th 2024
What We're Reading: Concierge Nonprofit Hospitals; Kaiser Permanente Elderly Care Program; Health Care Not Among Top Voter Issues
Published: October 21st 2024 | Updated: October 24th 2024
Lower Diagnostic Error Rates Found Among Hospitalized Patients During Care Transitions
Published: September 26th 2024 | Updated: October 1st 2024
Addressing Natural Disaster Takes Cooperation, Preparation to Ensure Patient Health
Published: May 9th 2024 | Updated: May 21st 2024
FDA Accepts Nivolumab Subcutaneous Injection Application, With Potential to Boost Access to PD-1 Inhibitors
Published: December 17th 2024 | Updated: December 22nd 2024
ICYMI: Highlights From IMS 2024
